New model more accurately classifies breast cancer risk
the ONA take:
Every year in America, more than a million women have breast biopsies that turn out to have benign findings. A new model, tested by a group of researchers led by Amy Degnim, M.D., a surgeon at Mayo Clinic, uses histologic features of biopsied breast tissue from benign findings along with demographic data to more accurately determine future breast cancer risk.
To test their new model, the investigators examined a cohort of approximately ten thousand women who received benign breast biopsy results from the Mayo Clinic but later developed breast cancer. The resulting age-specific incidence data was combined with a relative risk model created from both matched controls and 377 patients that later developed breast cancer.
Risk predictions from the new model were compared to the current standard, the Breast Cancer Risk Assessment Tool (BCRAT). The concordance statistic (both in the model development series and the validation series) was found to be higher in the new model than from the BCRAT.
A more accurate model for early breast cancer prediction could prove extremely useful, given that women with benign breast disease stand a higher risk of eventually developing breast cancer. This research was published in the Journal of Clinical Oncology.
Histologic features of biopsied breast tissue from benign findings along with demographic data to more accurately determine risk.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- LIVESTRONG Exercise Program Improves QoL in Cancer Survivors
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|